The Aroma Season eye mask is filled with natural flax seeds to offer a slightly compressive, non-toxic remedy and a design ...

The U.S. Food and Drug Administration has once again declined to approve Aldeyra Therapeutics treatment for dry eye disease, ...

The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish ...

If you’re looking for dry eye relief, we found a cordless, heated eye massager mask on sale for 48% off its typical list ...

The FDA rejected Aldeyra's resubmission for reproxalap, citing efficacy concerns. The company plans another trial and aims to ...

The FDA has set back Aldeyra Therapeutics’ ambitions to win approval for its dry eye disease, rejecting its second ...

Aldeyra Therapeutics shares fell 73% to $1.42 in the regular session after it reported a Food and Drug Administration complete response letter for reproxalap for treatment of dry eye disease. The ...

Miebo produced substantial symptom relief in patients with dry eye disease during the first day and succeeding weeks of ...

The FDA issued a complete response letter for the resubmission of the reproxalap new drug application for the treatment of ...

Shares of Aldeyra Therapeutics, Inc. (ALDX) slumped nearly 71% on Thursday morning after it said that the U.S. Food and Drug ...

The Company expects to have topline data from 2 trials assessing the effect of reproxalap on dry eye disease symptoms available in the second quarter of 2025.

Shares of Aldeyra Therapeutics plummeted nearly 75% Thursday morning after the Food and Drug Administration said the ...